Cart 0

QY Research

China Chronic Idiopathic Constipation (CIC) Drugs Market Research Report 2017

$3,200.00

Report Published By: QY Research
Publication Date : Feb-17
No. Of Pages: 122

Notes:
Sales, means the sales volume of Chronic Idiopathic Constipation (CIC) Drugs
Revenue, means the sales value of Chronic Idiopathic Constipation (CIC) Drugs

This report studies Chronic Idiopathic Constipation (CIC) Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Actavis
Chugai Pharmaceutical
Ferring International Center S.A.
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding AG
Sanofi
Bayer AG
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals
Progenics Pharmaceuticals

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Lubiprostone
Linaclotide
Others
Split by Application, this report focuses on consumption, market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs in each application, can be divided into
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others

Table of Contents

China Chronic Idiopathic Constipation (CIC) Drugs Market Research Report 2017
1 Chronic Idiopathic Constipation (CIC) Drugs Market Overview
1.1 Product Overview and Scope of Chronic Idiopathic Constipation (CIC) Drugs
1.2 Chronic Idiopathic Constipation (CIC) Drugs Segment by Type
1.2.1 China Production Market Share of Chronic Idiopathic Constipation (CIC) Drugs Type in 2015
1.2.2 Lubiprostone
1.2.3 Linaclotide
1.2.4 Others
1.3 Applications of Chronic Idiopathic Constipation (CIC) Drugs
1.3.1 Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application in 2015
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory Surgical Centres
1.3.4 Long Term Care Centres
1.3.5 Others
1.4 China Market Size (Value) of Chronic Idiopathic Constipation (CIC) Drugs (2012-2022)
1.5 China Chronic Idiopathic Constipation (CIC) Drugs Status and Outlook
1.6 Government Policies

2 China Chronic Idiopathic Constipation (CIC) Drugs Market Competition by Manufacturers
2.1 China Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Chronic Idiopathic Constipation (CIC) Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chronic Idiopathic Constipation (CIC) Drugs Market Competitive Situation and Trends
2.5.1 Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Rate
2.5.2 Chronic Idiopathic Constipation (CIC) Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Profiles/Analysis
3.1 Actavis
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.1.2.1 Lubiprostone
3.1.2.2 Linaclotide
3.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Chugai Pharmaceutical
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.2.2.1 Lubiprostone
3.2.2.2 Linaclotide
3.2.3 Chugai Pharmaceutical 122 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Ferring International Center S.A.
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.3.2.1 Lubiprostone
3.3.2.2 Linaclotide
3.3.3 Ferring International Center S.A. 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Synergy Pharmaceuticals
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.4.2.1 Lubiprostone
3.4.2.2 Linaclotide
3.4.3 Synergy Pharmaceuticals Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Pfizer
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.5.2.1 Lubiprostone
3.5.2.2 Linaclotide
3.5.3 Pfizer Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 GlaxoSmithKline
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.6.2.1 Lubiprostone
3.6.2.2 Linaclotide
3.6.3 GlaxoSmithKline Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Roche Holding AG
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.7.2.1 Lubiprostone
3.7.2.2 Linaclotide
3.7.3 Roche Holding AG Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Sanofi
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.8.2.1 Lubiprostone
3.8.2.2 Linaclotide
3.8.3 Sanofi Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Bayer AG
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.9.2.1 Lubiprostone
3.9.2.2 Linaclotide
3.9.3 Bayer AG Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Salix Pharmaceuticals Ltd
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
3.10.2.1 Lubiprostone
3.10.2.2 Linaclotide
3.10.3 Salix Pharmaceuticals Ltd Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Sucampo Pharmaceuticals Inc
3.12 Ironwood Pharmaceuticals
3.13 Progenics Pharmaceuticals

4 China Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production and Growth (2012-2017)
4.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth (2012-2017)
4.3 China Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export and Import (2012-2017)

5 China Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Chronic Idiopathic Constipation (CIC) Drugs Production and Market Share by Type (2012-2017)
5.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2012-2017)
5.4 China Chronic Idiopathic Constipation (CIC) Drugs Production Growth by Type (2012-2017)

6 China Chronic Idiopathic Constipation (CIC) Drugs Market Analysis by Application
6.1 China Chronic Idiopathic Constipation (CIC) Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaChronic Idiopathic Constipation (CIC) Drugs Market Analysis by Regions (Provinces)
7.1 China Chronic Idiopathic Constipation (CIC) Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Chronic Idiopathic Constipation (CIC) Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Chronic Idiopathic Constipation (CIC) Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Chronic Idiopathic Constipation (CIC) Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Chronic Idiopathic Constipation (CIC) Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export and Import (2012-2017)

8 Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Cost Analysis
8.1 Chronic Idiopathic Constipation (CIC) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Chronic Idiopathic Constipation (CIC) Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Chronic Idiopathic Constipation (CIC) Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Chronic Idiopathic Constipation (CIC) Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2017-2022)
12.1 China Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Chronic Idiopathic Constipation (CIC) Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Chronic Idiopathic Constipation (CIC) Drugs Production Forecast by Type (2017-2022)
12.4 China Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast by Application (2017-2022)
12.5 China Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Chronic Idiopathic Constipation (CIC) Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Chronic Idiopathic Constipation (CIC) Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


* indicates required information

* indicates required information


Share this Product


More from this collection